Bobby Zubis

Bobby Zubis has a diverse work experience spanning multiple industries. Bobby currently holds the position of Director Corporate Development at Resolution Therapeutics, starting in December 2022. Prior to this, Bobby worked as a Partnerships Lead at Genomics plc from February 2022 to November 2022. Before that, they were a Manager at Monitor Deloitte, specializing in strategy and advisory for healthcare and life sciences companies, from August 2021 to February 2022. Bobby also served as a Senior Consultant at Monitor Deloitte from July 2019 to September 2021. Additionally, Bobby co-founded Shaka Cuts Ltd in August 2019 and served as a Co-Founder until June 2021. Bobby began their career as an Associate at IQVIA from September 2016 to July 2018, and later worked as an Associate Consultant from August 2018 to May 2019.

Bobby Zubis attended the University of Warwick from 2013 to 2016, where they obtained a Bachelor of Science (BSc) degree in Biomedical Science (Hons).